EP-1168: Phase II trial of hypofractionated VMAT treatment for early stage breast cancer: 2-years outcomes. (April 2016) - De Rose, F.; Franceschini, D.; Fogliata, A.; Iftode, C.S.; Villa, E.; Ascolese, A.M.; Navarria, P.; Franzese, C.; Comito, T.; Tozzi, A.; Clerici, E.; Liardo, R.L.E.; et al.